Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: smh who wrote (1106)	5/18/2000 10:16:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

I spent an hour or so slogging through ASCO abstracts. Didn't see anything really sensational, although there are so many that who knows what I may have missed. The Maxim maxamine abstract looks good: asco00.agora.com Nothing too exciting from MOGN based on what's in the abstracts - looks like the NCI ovarian trial (which has much better results than their own ovarian trial that's being presented) isn't being presented here. NERX is strong today - I picked up a very few shares recently (I blew out my previous holdings in the huge run-up pre-crash). Peter